Description: |
VER-50589 inhibits the intrinsic ATPase activity of recombinant yeast Hsp90 with IC50 of 143 nM, and produces antiproliferative activity in a panel of human cancer cell lines and nontumorigenic cells in vitro. VER-50589 causes induction of HSP72 and HSP27 alongside depletion of client proteins, including C-RAF, B-RAF, and survivin, and the protein arginine methyltransferase PRMT5, which further result in cell cycle arrest and apoptosis. In HCT116 human colon cancer xenografts, VER-50589 (100 mg/kg i.p.) results in a statistically significant reduction of ∼30% in tumor volume and weight, as well as induction of HSP72 and depletion of ERBB2 and C-RAF. . For the detailed information of VER-50589, the solubility of VER-50589 in water, the solubility of VER-50589 in DMSO, the solubility of VER-50589 in PBS buffer, the animal experiment (test) of VER-50589, the cell expriment (test) of VER-50589, the in vivo, in vitro and clinical trial test of VER-50589, the EC50, IC50,and affinity,of VER-50589, Please contact DC Chemicals. |